{"id":"https://openalex.org/W1995101760","doi":"https://doi.org/10.1097/qai.0000000000000301","title":"GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects","display_name":"GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects","publication_year":2014,"publication_date":"2014-08-20","ids":{"openalex":"https://openalex.org/W1995101760","doi":"https://doi.org/10.1097/qai.0000000000000301","mag":"1995101760","pmid":"https://pubmed.ncbi.nlm.nih.gov/25140909"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0000000000000301","doi":"https://doi.org/10.1097/qai.0000000000000301","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0000000000000301","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044001938","display_name":"William R. Spreen","orcid":"https://orcid.org/0000-0002-8180-1517","observed_orcids":["https://orcid.org/0000-0002-8180-1517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Spreen","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","All authors are employees of and own stock in GlaxoSmithKline","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009272615","display_name":"Susan L. Ford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan L. Ford","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100751117","display_name":"Shuguang Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuguang Chen","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061873181","display_name":"David A. Wilfret","orcid":"https://orcid.org/0009-0003-9068-8231","observed_orcids":["https://orcid.org/0009-0003-9068-8231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Wilfret","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008716404","display_name":"David M. Margolis","orcid":"https://orcid.org/0000-0001-5714-0002","observed_orcids":["https://orcid.org/0000-0001-5714-0002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Margolis","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042067535","display_name":"Elizabeth P. Gould","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Gould","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063738784","display_name":"Stephen C. Piscitelli","orcid":"https://orcid.org/0000-0002-4528-3273","observed_orcids":["https://orcid.org/0000-0002-4528-3273"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen Piscitelli","raw_affiliation_strings":["All authors are employees of and own stock in GlaxoSmithKline","GlaxoSmithKline, Research Triangle Park, NC","Stephen Piscitelli, PharmD, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709 (e-mail: [email\u00a0protected])","Accepted July 01, 2014","Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","Received April 04, 2014","Supported by ViiV Healthcare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors are employees of and own stock in GlaxoSmithKline","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC","institution_ids":[]},{"raw_affiliation_string":"Stephen Piscitelli, PharmD, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709 (e-mail: [email\u00a0protected])","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Accepted July 01, 2014","institution_ids":[]},{"raw_affiliation_string":"Presented in part at the XIX International AIDS Conference, July 22\u201327, 2012, Washington, DC","institution_ids":[]},{"raw_affiliation_string":"Received April 04, 2014","institution_ids":[]},{"raw_affiliation_string":"Supported by ViiV Healthcare","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063738784"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":null,"apc_paid":null,"fwci":9.3487,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.9850569,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"67","issue":"5","first_page":"481","last_page":"486"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-integrase-inhibitors","display_name":"HIV-1 integrase inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/long-acting-injectables","display_name":"long-acting injectables","score":0.8970000147819519},{"id":"https://openalex.org/keywords/nanoparticle-suspensions","display_name":"nanoparticle suspensions","score":0.8050000071525574},{"id":"https://openalex.org/keywords/plasma-pharmacokinetics","display_name":"plasma pharmacokinetics","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tissue-pharmacokinetics","display_name":"tissue pharmacokinetics","score":0.875},{"id":"https://openalex.org/keywords/rectal-tissue","display_name":"rectal tissue","score":0.9599999785423279},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.9599999785423279},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":1.0},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.7910000085830688},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8975160121917725},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7942885160446167},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6667288541793823},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6449015140533447},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5253569483757019},{"id":"https://openalex.org/C2776873419","wikidata":"https://www.wikidata.org/wiki/Q419892","display_name":"Rectal administration","level":2,"score":0.4410891532897949},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.4364212453365326},{"id":"https://openalex.org/C2777300098","wikidata":"https://www.wikidata.org/wiki/Q1164665","display_name":"Subcutaneous tissue","level":2,"score":0.41830143332481384},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3574076294898987},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3527143597602844},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.334589421749115},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25412899255752563},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11151275038719177},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D054659","descriptor_name":"Diketopiperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/qai.0000000000000301","doi":"https://doi.org/10.1097/qai.0000000000000301","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0000000000000301","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:25140909","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25140909","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1974810704","https://openalex.org/W1990455141","https://openalex.org/W2075144974","https://openalex.org/W2081607626","https://openalex.org/W2091873536"],"related_works":["https://openalex.org/W2024823439","https://openalex.org/W2320058171","https://openalex.org/W2081607626","https://openalex.org/W1997755754","https://openalex.org/W4378516235","https://openalex.org/W3177529243","https://openalex.org/W2791404636","https://openalex.org/W3193289953","https://openalex.org/W3108345840","https://openalex.org/W3157300339"],"abstract_inverted_index":{"BACKGROUND:":[0],"GSK1265744":[1],"(744)":[2],"is":[3],"an":[4],"HIV-1":[5],"integrase":[6],"inhibitor":[7],"in":[8,49,82,101,176],"clinical":[9],"development":[10],"as":[11,55,174,231],"a":[12,40,56,120,232],"long-acting":[13],"(LA)":[14],"injectable":[15],"formulation.":[16],"This":[17,38],"study":[18,46],"evaluated":[19],"plasma":[20,219],"and":[21,66,74,78,94,104,106,109,133,142,146,149,158,208],"tissue":[22,111,135,210],"pharmacokinetics":[23],"after":[24,161,190],"single-dose":[25],"administration":[26],"of":[27,47,62,84,122,166,217],"744":[28,48,52,99,127,153,192,225],"LA":[29,100,154,193,226],"administered":[30,54],"by":[31],"intramuscular":[32],"(IM)":[33],"or":[34,125,234,239],"subcutaneous":[35],"injections.":[36,163],"METHODS:":[37],"was":[39,53,117,155],"phase":[41],"I,":[42],"open-label,":[43],"9-cohort,":[44],"parallel":[45],"healthy":[50],"subjects.":[51],"200":[57],"mg/mL":[58],"nanosuspension":[59],"at":[60,139],"doses":[61],"100-800":[63],"mg":[64,68,195],"IM":[65,196],"100-400":[67],"subcutaneous.":[69],"RESULTS:":[70],"Eight":[71],"(6":[72],"active":[73,98],"2":[75,141],"placebo)":[76],"male":[77],"female":[79],"subjects":[80,167],"participated":[81],"each":[83],"the":[85],"first":[86],"7":[87],"cohorts.":[88],"All":[89],"8":[90,103,143],"subjects,":[91],"4":[92,95,148],"males":[93],"females,":[96],"received":[97],"cohorts":[102],"9":[105],"underwent":[107],"rectal":[108],"cervicovaginal":[110,134,209],"sampling,":[112],"respectively.":[113],"Plasma":[114,178],"pharmacokinetic":[115],"sampling":[116],"performed":[118,138],"for":[119,203],"minimum":[121],"12":[123,150],"weeks":[124,140,147,189],"until":[126],"concentrations":[128,185,199,211],"were":[129,137,181],"\u22640.1":[130],"\u03bcg/mL.":[131],"Rectal":[132,207],"biopsies":[136],"(cohort":[144,151],"8)":[145],"9).":[152],"generally":[156],"safe":[157],"well":[159],"tolerated":[160],"single":[162],"A":[164],"majority":[165],"reported":[168],"injection":[169,227],"site":[170],"reactions,":[171],"all":[172],"graded":[173],"mild":[175],"intensity.":[177],"concentration-time":[179],"profiles":[180],"prolonged":[182],"with":[183],"measureable":[184],"up":[186],"to":[187,215],"52":[188],"dosing.":[191],"800":[194],"achieved":[197],"mean":[198],"above":[200],"protein":[201],"adjusted-IC90":[202],"approximately":[204],"16":[205],"weeks.":[206],"ranged":[212],"from":[213],"<8%":[214],"28%":[216],"corresponding":[218],"concentrations.":[220],"CONCLUSIONS:":[221],"These":[222],"data":[223],"suggest":[224],"has":[228],"potential":[229],"application":[230],"monthly":[233],"less":[235],"frequent":[236],"HIV":[237],"treatment":[238],"prevention":[240],"agent.":[241]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":21}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}